Analysis of Top 10 Specialty Pharmaceutical Companies

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.

Table of Contents

Analysis of Top 10 Specialty Pharmaceutical Companies, Executive SummaryExecutive SummaryExecutive SummaryAnalysis of Top 10 Specialty Pharmaceutical Companies, IntroductionMarket OverviewTop Ten Specialty Pharmaceutical CompaniesMarket StructureResearch MethodologyFrost & Sullivan AwardsGrowth Strategy Leadership AwardMarket Leadership AwardProduct Line Strategy AwardAnalysis of Top 10 Specialty Pharmaceutical Companies, Company AnalysisTeva Pharmaceutical Industries LtdCompany ProfileProduct AnalysisSWOT AnalysisForest Laboratories IncCompany ProfileProduct AnalysisSWOT AnalysisAllergan IncCompany ProfileProduct AnalysisSWOT AnalysisWatson Pharmaceuticals IncCompany ProfileProduct AnalysisSWOT AnalysisShire Pharmaceuticals GroupCompany ProfileProduct AnalysisSWOT AnalysisKing Pharmaceuticals IncCompany ProfileProduct AnalysisSWOT AnalysisAndrx CorporationCompany ProfileProduct AnalysisSWOT AnalysisBarr Pharmaceuticals IncCompany ProfileProduct AnalysisSWOT AnalysisCephalon IncCompany ProfileProduct AnalysisSWOT AnalysisEndo PharmaceuticalsCompany ProfileProduct AnalysisSWOT AnalysisAnalysis of Top 10 Specialty Pharmaceutical Companies, Decision Support DatabasesPharmaceuticals and BiotechnologyPharmaceutical R&D ExpenditurePercent Pharmaceutical R&D ExpenditureTotal Healthcare ExpenditureBiotechnology CompaniesNumber of Physicians




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.